Patent: 9,422,322
✉ Email this page to a colleague
Summary for Patent: 9,422,322
Title: | Substituted nucleosides, nucleotides and analogs thereof |
Abstract: | Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection, with a nucleoside, a nucleotide and an analog thereof. |
Inventor(s): | Dyatkina; Natalia (Mountain View, CA), Wang; Guangyi (Carlsbad, CA), Beigelman; Leonid (San Mateo, CA), Rajwanshi; Vivek Kumar (Cupertino, CA) |
Assignee: | Alios BioPharma, Inc. (South San Francisco, CA) |
Application Number: | 14/312,990 |
Patent Claims: | see list of patent claims |
Details for Patent 9,422,322
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | For Injection | 103770 | 06/19/1998 | ⤷ Try a Trial | 2039-02-26 |
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | Injection | 103770 | 07/23/2004 | ⤷ Try a Trial | 2039-02-26 |
Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | 06/04/2004 | ⤷ Try a Trial | 2039-02-26 | |
Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | 06/13/2008 | ⤷ Try a Trial | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |